Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
402
-
Total 13F shares, excl. options
-
89.2M
-
Shares change
-
+4.24M
-
Total reported value, excl. options
-
$13.6B
-
Value change
-
+$676M
-
Put/Call ratio
-
0.83
-
Number of buys
-
187
-
Number of sells
-
-194
-
Price
-
$152.65
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2021
482 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2021.
Guardant Health, Inc. - Common Stock (GH) has 402 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.2M shares
of 124M outstanding shares and own 71.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.14M shares), FMR LLC (6.7M shares), SB INVESTMENT ADVISERS (UK) LTD (6.18M shares), BlackRock Inc. (5.4M shares), MORGAN STANLEY (4.43M shares), Clearbridge Investments, LLC (3.05M shares), VIKING GLOBAL INVESTORS LP (2.92M shares), JENNISON ASSOCIATES LLC (2.73M shares), FRED ALGER MANAGEMENT, LLC (2.64M shares), and Nuveen Asset Management, LLC (2.31M shares).
This table shows the top 402 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.